Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009 Thomas KühnePaul Imbach Editorial 07 May 2010 Pages: 1 - 2
The working group for “basic science” in ITP at the International Cooperative ITP Study Group (ICIS) Kenneth J. ClemetsonSimon Panzer Basic Science 22 April 2010 Pages: 3 - 4
Consensus Paper—ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia Hannah TamaryJelena RoganovicDiane J. Nugent Management Endpoints Open access 01 April 2010 Pages: 5 - 10
Diagnosis and management of chronic ITP: comments from an ICIS expert group John David GraingerPaula H. B. Bolton-MaggsAndre Tichelli Review Article 07 May 2010 Pages: 11 - 17
Future research in ITP: an ICIS consensus James L. ZehnderJohn W. SempleICIS Study Group on Future Research in ITP Future Research 23 March 2010 Pages: 19 - 23
The role of Fcγ receptors in murine autoimmune thrombocytopenia Markus BiburgerSusanne AschermannFalk Nimmerjahn Basic Science 24 February 2010 Pages: 25 - 30
Mechanisms of platelet recovery in ITP associated with therapy Sophie J. Y. PangAlan H. Lazarus Basic Science 24 February 2010 Pages: 31 - 35
Animal models of immune thrombocytopenia (ITP) John W. Semple Basic Science 25 March 2010 Pages: 37 - 44
Investigating caspases and other markers of apoptosis in ITP Oliver SpeerMarkus Schmugge Basic Science Open access 22 April 2010 Pages: 45 - 46
Evaluating bleeding severity in immune thrombocytopenia (ITP) Cindy E. Neunert Management Endpoints 23 March 2010 Pages: 47 - 50
Health-related quality of life outcomes for patients with immune thrombocytopenic purpura Robert J. KlaassenNancy L. Young Management Endpoints 12 May 2010 Pages: 51 - 54
Treatment of chronic immune thrombocytopenic purpura in adults Bertrand GodeauMarc Michel Chronic ITP 14 April 2010 Pages: 55 - 60
Chronic immune thrombocytopenic purpura—who needs medication? Paula H. B. Bolton-MaggsVictoria S. L. Kok Chronic ITP 23 March 2010 Pages: 61 - 65
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia Thomas KühnePaul Imbach Chronic ITP 20 April 2010 Pages: 67 - 74
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects Vibha JawaMartha HokomNarendra Chirmule Original Article Open access 13 February 2010 Pages: 75 - 85
Moving towards a new era in the management of chronic immune thrombocytopenia Hans WadenvikBob Olsson Chronic ITP 26 March 2010 Pages: 87 - 93
Genetic studies in pediatric ITP: outlook, feasibility, and requirements Anke K. BergmannRachael F. GraceEllis J. Neufeld Future Research 23 March 2010 Pages: 95 - 103